Protection against Murine Leukemia Virus-Induced Spongiform Myeloencephalopathy in Mice Overexpressing Bcl-2 but Not in Mice Deficient for Interleukin-6, Inducible Nitric Oxide Synthetase, ICE, Fas, Fas Ligand, or TNF-R1 Genes

Journal of Virology

Volumn 77, Issue 24, 2003, Pages 13161-13170

  Jolicoeur, Paul ^a,b,c   Hu, Chunyan ^a   Mak, Tak W ^d   Martinou, Jean Claude ^e   Kay, Denis G ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d AMGEN INSTITUTE   (Canada)

^e UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ARTICLE; BRAIN DISEASE; BRAIN SPONGIOSIS; CELL PROTECTION; CHIMERA; EFFECTOR CELL; ENCEPHALOMYELITIS; ENVELOPE GENE; GENE OVEREXPRESSION; INFLAMMATORY CELL; MOUSE; MURINE LEUKEMIA VIRUS; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS INDUCTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD95; CASPASE 1; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; FAS LIGAND PROTEIN; INTERLEUKIN-6; LEUKEMIA VIRUS, MURINE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE DEGENERATION; NEURONS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RETROVIRIDAE INFECTIONS;

EID: 0345599098     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.24.13161-13170.2003     Document Type: Article

References (114)

1. Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326.
2. Akassoglou, K., J. Bauer, G. Kassiotis, M. Pasparakis, H. Lassmann, G. Kollias, and L. Probert. 1998. Oligodendrocyte apoptosis and primary demyelinaytion induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153:801-813.
3. Allsopp, T. E., S. Wyatt, H. F. Paterson, and A. M. Davies. 1993. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307.
4. Andrews, J. M., and M. B. Gardner. 1974. Lower motor neuron degeneration associated with type C RNA virus infection in mice: neuropathological features. J. Neuropathol. Exp. Neurol. 33:285-307.
5. Askovic, S., C. Favara, F. J. McAtee, and J. L. Portis. 2001. Increased expression of MIP-Iα and MIP-1Β mRNAs in the brain correlates spatially and temporally with the spongiform neurodegeneration induced by a murine oncornavirus. J. Virol. 75:2665-2674.
6. Bagasra, O., F. H. Michaels, Y. M. Zheng, L. E. Bobroski, S. V. Spitsin, Z. F. Fu, R. Tawadros, and H. Koprowski. 1995. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92:12041-12045.
7. Baker, S. J., and E. P. Reddy. 1996, Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9.
8. Baszler, T. V., and J. F. Zachary. 1990. Murine retroviral-induced spongi-form neuronal degeneration parallels resident microglial cell infection: ultrastructural findings. Lab. Investig. 63:612-623.
9. Baszler, T. V., and J. F. Zachary. 1991. Murine retroviral neurovirulence correlates with an enhanced ability of virus to infect selectively, replicate in, and activate resident microglial cells. Am. J. Pathol. 138:655-671.
10. Bauer, J., S. Strauss, U. Schreiter-Gasser, U. Ganter, P. Schlegel, I. Witt, B. Yolk, and M. Berger. 1991. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:111-114.
11. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717-1725.
12. Brooks, B. R., J. R. Swarz, and R. T. Johnson. 1980. Spongiform polioencephalomyelopathy caused by a murine retrovirus. I. Pathogenesis of infection in newborn mice. Lab. Investig. 43:480-486.
13. Campbell, I. L., C. R. Abraham, E. Masliah, P. Kemper, J. D. Inglis, and M. B. M. L. Oldstone. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90:10061-10065.
14. Choe, W., G. Stoica, W. Lynn, and P. K. Wong. 1998. Neurodegeneration induced by MoMuLV-tsl and increased expression of Fas and TNF-alpha in the central nervous system. Brain Res. 779:1-8.
15. Choi, D. W. 1993. Nitric oxide: foe or friend to the injured brain? Proc. Natl. Acad. Sci. USA 90:9741-9743.
16. Cleveland, J. L., and J. N. Ihle. 1995. Contenders in FasL/TNF death signaling. Cell 81:479-482.
17. Czub, M., S. Czub, F. J. McAtee, and J. L. Portis. 1991. Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication. J. Virol. 65:2539-2544.
18. Czub, M., S. Czub, M. Rappold, S. Mazgareanu, S. Schwender, M. Demuth, A. Hein, and R. Dorries. 1995. Murine leukemia virus-induced neurodedegeneration of rats: enhancement of neuropathogenicity correlates with enhanced viral tropism for macrophages, microglia, and brain vascular cells. Virology 214:239-244.
19. Czub, M., F. J. McAtee, and J. L. Portis. 1992. Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period. J. Virol. 66:3298-3305.
20. Davies, A. M. 1995. The Bcl-2 family of proteins, and the regulation of neuronal survival. Trends Neurosci. 18:355-358.
21. Dawson, V. L., T. M. Dawson, E. D. London, D. S. Bredt, and S. H. Snyder. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88:6368-6371.
22. Dawson, V. L., T. M. Dawson, G. R. Uhl, and S. H. Snyder. 1993. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA 90:3256-3259.
23. DesGroseillers, L., M. Barrette, and P. Jolicoeur. 1984. Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic retrovirus. J. Virol. 52:356-363.
24. DesGroseillers, L., E. Rassart, and P. Jolicoeur. 1983. Thymotropism of murine leukemia virus is conferred by its long terminal repeat. Proc. Natl. Acad. Sci. USA 80:4203-4207.
25. Dowling, P., G. Shang, S. Raval, J. Menonna, S. Cook, and W. Husar. 1996. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1513-1518.
26. Dubois-Dauphin, M., H. Frankowski, Y. Tsujimoto, J. Huarte, and J. C. Martinou. 1994. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. USA 91:3309-3313.
27. Eugster, H. P., K. Frei, M. Kopf, H. Lassmann, and A. Fontana. 1998. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:2178-2187.
28. Farlie, P. G., R. Dringen, S. M. Rees, G. Kannourakis, and O. Bernard. 1995. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. USA 92:4397-4401.
29. Friedlander, R. M., R. H. Brown, V. Gagliardini, J. Wang, and J. Yuan. 1997. Inhibition of ICE slows ALS in mice. Nature 388:31.
30. Furlan, R., G. Martino, F. Galbiati, P. L. Poliani, S. Smiroldo, A. Bergami, G. Desina, G. Comi, R. Flavell, M. S. Su, and L. Adorini. 1999. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J. Immunol. 163:2403-2409.
31. Gallo, P., K. Frei, C. Rordorf, J. Lazdins, B. Tavolato, and A. Fontana. 1989. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23:109-116.
32. Gardner, M. B. 1978. Type-C viruses of wild mice: characterization and natural history of amphotropic, ecotropic and xenotropic murine leukemia viruses. Curr. Top. Microbiol. Immunol., 79:215-239.
33. Gardner, M. B. 1985. Retroviral spongiform polioencephalomyelopathy. Rev. Infect. Dis. 7:99-110.
34. Gardner, M. B. 1988. Neurotropic retroviruses of wild mice and macaques. Ann. Neurol. 23(Suppl.):S201-S206.
35. Gardner, M. B., B. E. Henderson, J. E. Officer, R. W. Rongey, J. C. Parker, C. Oliver, J. D. Estes, and R. J. Huebner. 1973. A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J. Natl. Cancer Inst. 51:1243-1254.
36. Gravel, C., D. G. Kay, and P. Jolicoeur. 1993. Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J. Virol. 67:6648-6658.
37. Gross, A., J. M. McDonnell, and S. J. Korsmeyer. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899-1911.
38. Hara, H., R. M. Friedlander, V. Gagliardini, C. Ayata, K. Fink, Z. Huang, M. Shimizu-Sasamata, J. Yuan, and M. A. Moskowitz. 1997. Inhibition of interleukin 1Β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94:2007-2012.
39. Hasenkrug, K. J., S. J. Robertson, J. Porti, F. McAtee, J. Nishio, and B. Chesebro. 1996. Two separate envelope regions influence induction of brain disease by a polytropic murine retrovirus (FMCF98). J. Virol. 70:4825-4828.
40. Henkart, P. A. 1996. Ice family proteases: mediators of all apoptotic cell death? Immunity 4:195-201.
41. Hockenbery, D. M., Z. N. Oltvai, X. M. Yin, C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
42. Hoffman, P. M., E. F. Cimino, D. S. Robbins, R. D. Broadwell, J. M. Powers, and S. K. Ruscetti. 1992. Cellular tropism and localization in the rodent nervous system of a neuropathogenic variant of Friend murine leukemia virus. Lab. Investig. 67:314-321.
43. Hoffman, P. M., O. M. Pitts, J. A. Bilello, and E. F. Cimino. 1988. Retrovirus induced motor neuron degeneration. Rev. Neurol. 144:676-679.
44. Hoffman, F. M., D. R. Hinton, K. Johnson, and J. E. Merrill. 1989. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:607-612.
45. Hooper, D. C., S. T. Ohnishi, R. Kean, Y. Numagami, B. Dietzschold, and H. Koprowski. 1995. Local nitric oxide, production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92:5312-5316.
46. Huang, M., C. Simard, D. G. Kay, and P. Jolicoeur. 1991. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol. 65:6562-6571.
47. Iadecola, C., X. Xu, F. Zhang, E. E. el Fakahany, and M. E. Ross. 1995. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15:52-59.
48. Jacobson, M. D., and M. C. Raff. 1995. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814-816.
49. Jinno-Oue, A., S. G. Wilt, C. Hanson, N. V. Dugger, P. M. Hoffman, M. Masuda, and S. K. Ruscetti. 2003. Expression of inducible nitric oxide synthase and elevation of tyrosine nitration of a 32-kilodalton cellular protein in brain capillary endothelial cells from rats infected with a neuro-pathogenic murine leukemia virus. J. Virol. 77:5145-5151.
50. Jolicoeur, P. 1990. Retrovirus-induced lower motor neuron disease in mice: a model for amyotrophic lateral sclerosis and human spongiform neurologicaI diseases, p. 52-82. In A. J. Hudson (ed.), Amyotrophic lateral sclerosis. Concepts in pathogenesis and etiology. University of Toronto Press, Toronto, Canada.
51. Jolicoeur, P. 1991. Neuronal loss in a lower motor neuron disease induced by a murine retrovirus. Can. J. Neurol. Sci. 18:411-413.
52. Jolicoeur, P., and D. Baltimore. 1975. Effect of the Fv-1 locus on the titration of murine leukemia viruses. J. Virol, 16:1593-1598.
53. Jolicoeur, P., C. Gravel, and D. G. Kay. 1992. Pathogenesis of murine spongiform myeloencephalopathy induced by a murine retrovirus, p. 199-224. Humana Press, Totowa, New Jersey.
54. Jolicoeur, P., G. Masse, and D. G. Kay. 1996. The prion gene is dispensable for the development of spongiform myeloencephalopathy induced by the neurovirulent Cas-Br-E murine leukemia virus. J. Virol. 70:9031-9034.
55. Jolicoeur, P., N. Nicolaiew, L. DesGroseillers, and E. Rassart. 1983. Molecular cloning of infectious viral DNA from ecotropic neurotropic wild mouse retrovirus. J. Virol. 45:1159-1163.
56. Jolicoeur, P., E. Rassart, L. DesGroseillers, Y. Robitaille, Y. Paquette, and D. G. Kay. 1991. Retrovirus-induced motor neuron disease of mice: molecular basis of neurotropism and paralysis. Adv. Neurol. 56:481-493.
57. Kane, D. J., T. A. Sarafian, R. Anton, H. Hahn, E. B. Gralla, J. S. Valentine, T. Ord, and D. E. Bredesen. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274-1277.
58. Kaufman, P. L. 1999. Nitric-oxide synthase and neurodegeneration/neuroprotection. Proc. Natl. Acad. Sci. USA 96:9455-9456.
59. Kay, D., C. Gravel, Y. Robitaille, and P. Jolicoeur. 1991. Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons. Proc. Natl. Acad. Sci. USA 88:1281-1285.
60. Kay, D. G., C. Gravel, F. Pothier, A. Laperričre, Y. Robitaille, and P. Jolicoeur. 1993. Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Proc. Natl. Acad. Sci. USA 90:4538-4542.
61. Keilhoff, G., B. Seidel, H. Noack, W. Tischmeyer, D. Stanek, and G. Wolf. 1996. Patterns of nitric oxide synthase at the messenger RNA and protein levels during early rat brain development. Neuroscience 75:1193-1201.
62. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Z. R. Kishimoto, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342.
63. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000-2003.
64. Li, M., V. O. Ona, C. Guegan, M. Chen, V. Jackson-Lewis, L. J. Andrews, A. J. Olszewski, P. E. Stieg, J. P. Lee, S. Przedborski, and R. M. Friedlander. 2000. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288:335-339.
65. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, and J. Salfeld. 1995. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80:401-411.
66. Liberatore, G. T., V. Jackson-Lewis, S. Vukosavic, A. S. Mandir, M. Vila, W. G. McAuliffe, V. L. Dawson, T. M. Dawson, and S. Przedborski. 1999. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5:1403-1409.
67. Lindholm, D., R. Heumann, M. Meyer, and H. Thoenen. 1987. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330:658-659.
68. Liu, X. H., D. Kwon, G. P. Schielke, G. Y. Yang, F. S. Silverstein, and J. D. Barks. 1999. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J. Cereb. Blood Flow Metab. 19:1099-1108.
69. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487-501.
70. Loddick, S. A., and N. J. Rothwell. 1999. Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1. Proc. Natl. Acad. Sci. USA 96:9449-9451.
71. Lowenstein, C. J., C. S. Glatt, D. S. Bredt, and S. H. Snyder. 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA 89:6711-6715.
72. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, and K. Hunter. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131-136.
73. Lynch, W. P., S. Czub, F. J. McAtee, S. F. Hayes, and J. L. Portis. 1991. Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 7:365-379.
74. Lynch, W. P., E. Y. Snyder, L. Qualtiere, J. L. Portis, and A. H. Sharpe. 1996. Late virus replication events in microglia are required for neurovirulent retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains. J. Virol. 70:8896-8907.
75. Martinou, J. C., M. Dubois-Dauphin, J. K. Staple, I. Rodriguez, H. M. M. Frankowski, P. Albertini, D. Talabot, S. Catsicas, and C. Pietra. 1994. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017-1030.
76. Masuda, M., P. M. Hoffman, and S. K. Ruscetti. 1993. Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitro. J. Virol. 67:4580-4587.
77. McCarter, J. A., J. K. Ball, and J. V. Frei. 1977. Lower limb paralysis induced in mice by a temperature-sensitive mutant of Moloney leukemia virus. J. Natl. Cancer Inst. 59:179-183.
78. Munk, C., J. Lohler, V. Prassolov, U. Just, M. Stockschlader, and C. Stocking. 1997. Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy. Proc. Natl. Acad. Sci. USA 94:5837-5842.
79. Nagra, R. M., M. P. Heyes, and C. A. Wiley. 1994. Viral load and its relationship to quinolinic acid, TNF alpha, and IL-6 levels in the CNS of retroviral infected mice. Mol. Chem. Neuropathol. 22:143-160.
80. Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
81. Nishimura, T., H. Akiyama, S. Yonehara, H. Kondo, K. Ikeda, M. Kato, E. Iseki, and K. Kosaka. 1995. Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res. 695:137-145.
82. Oldstone, M. B., P. W. Lampert, S. Lee, and F. J. Dixon. 1977. Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am. J. Pathol. 88:193-212.
83. Oldstone, M. B. A., F. Jensen, F. J. Dixon, and P. W. Lampert. 1980. Pathogenesis of the slow-disease of the central nervous system associated with wild mouse virus. II. Role of virus and host gene products. Virology 107:180-193.
84. Ona, V. O., M. Li, J. P. Vonsattel, L. J. Andrews, S. Q. Khan, W. M. Chung, A. S. Frey, A. S. Menon, X. J. Li, P. E. Stieg, J. Yuan, J. B. Penney, A. B. Young, J. H. Cha, and R. M. Friedlander. 1999. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399:263-267.
85. Owens, T., H. Wekerle, and J. Antel. 2001. Genetic models for CNS inflammation. Nat. Med. 7:161-166.
86. Paquette, Y., Z. Hanna, P. Savard, R. Brosseau, Y. Robitaille, and P. Jolicoeur. 1989. Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene. Proc. Natl. Acad. Sci. USA 86:3896-3900.
87. Peterson, K. E., S. J. Robertson, J. L. Portis, and B. Chesebro. 2001. Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses map to separate regions of the viral envelope gene. J. Virol. 75:2848-2856.
88. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
89. Pitts, O. M., J. M. Powers, J. A. Bilello, and P. M. Hoffman. 1987. Ultra-structural changes associated with retroviral replication in central nervous system capillary endothelial cells. Lab. Investig. 56:401-408.
90. Portis, J. L., S. Czub, C. F. Garon, and F. J. MeAtee. 1990. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus. J. Virol. 64:1648-1656.
91. Portis, J. L., S. Czub, S. Robertson, F. McAtee, and B. Chesebro. 1995. Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain. J. Virol. 69:8070-8075.
92. Portis, J. L., and W. P. Lynch. 1998. Dissecting the determinants of neuropathogenesis of the murine oncornaviruses. Virology 247:127-136.
93. Poulsen, D. J., S. J. Robertson, C. A. Favara, J. L. Portis, and B. W. Chesebro. 1998. Mapping of a neurovirulence determinant within the envelope protein of a polytropic murine retrovirus: induction of central nervous system disease by low levels of virus. Virology 248:199-207.
94. Robertson, S. J., K. J. Hasenkrug, B. Chesebro, and J. L. Portis. 1997. Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells. J. Virol. 71:5287-5294.
95. Schmidt, H. and U. Walter. 1994. NO at work. Cell 78:919-925.
96. Sharpe, A. H., J. J. Hunter, P. Chassler, and R. Jaenisch. 1990. Role of abortive retroviral infection of neurons in spongiform CNS degeneration. Nature 346:181-183.
97. Simmons, M. L., and S. Murphy. 1992. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59:897-905.
98. Swarz, J. R., B. R. Brooks, and R. T. Johnson. 1981. Spongiform polioencephalomyelopathy caused by a murine retrovirus. II. Ultrastructural localization of virus replication and spongiform changes in the central nervous system. Neuropathol. Appl. Neurobiol. 7:365-380.
99. Szurek, P. F., P. H. Yuen, J. K. Ball, and P. K. Wong. 1990. A Val-25-to-Ile substitution in the envelope precursor polyprotein, gPr80env, is responsible for the temperature sensitivity, inefficient processing of gPr80env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB. J. Virol. 64:467-475.
100. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, and T. N. S. Suda. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976.
101. Venters, H. D., R. Dantzer, and K. W. Kelley. 2000. A new concept in neurodegeneration: TNFα is a silencer of survival signals. Trends Neurosci. 23:175-180.
102. Wallace, M. N., and K. Fredens. 1992. Activated astrocytes of the mouse hippocampus contain high levels of NADPH-diaphorase. Neuroreport 3:953-956.
103. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317.
104. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
105. Wesselingh, S. L., C. Power, J. D. Glass, W. R. Tyor, J. C. McArthur, J. M. Farber, J. W. Griffin, and D. E. Griffin. 1993. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33:576-582.
106. Wilt, S. G., N. V. Dugger, N. D. Hitt, and P. M. Hoffman. 2000. Evidence for oxidative damage in a murine leukemia virus-induced neurodegeneration. J. Neurosci. Res. 62:440-450.
107. Wong, P. K. 1990. Moloney murine leukemia virus temperature-sensitive mutants: a model for retrovirus-induced neurologic disorders. Curr. Top. Microbiol. Immunol. 160:29-60.
108. Wong, P. K., E. Floyd, and P. F. Szurek. 1991. High susceptibility of FVB/N mice to the paralytic disease induced by tsl, a mutant of Moloney murine leukemia virus TB. Virology 180:365-371.
109. Wong, P. K., M. M. Soong, R. MacLeod, G. E. Gallick, and P. H. Yuen. 1983. A group of temperature-sensitive mutants of Moloney leukemia virus which is defective in cleavage of env precursor polypeptide in infected cells also induces hind-limb paralysis in newborn CFW/D mice. Virology 125:513-518.
110. Wong, P. K. Y., and P. H. Yuen. 1992. Molecular basis of neurologic disorders induced by a mutant, tsl, of Moloney murine leukemia virus, p. 161-197. Humana Press. Inc., Totowa, N.J.
111. Yu, Y. E., W. Choe, W. Zhang, G. Stoica, and P. K. Wong. 1997. Development of pathological lesions in the central nervous system of transgenic mice expressing the env gene of tsl Moloney murine leukemia virus in the absence of the viral gag and pol genes and viral replication. J. Neurovirol. 3:274-282.
112. Yuan, J., and B. A. Yankner. 2000. Apoptosis in the nervous system. Nature 407:802-809.
113. Zachary, J. F., C. J. Knupp, and P. K. Wong. 1986. Noninflammatory spongiform polioencephalomyelopathy caused by a neurotropic temperature-sensitive mutant of Moloney murine leukemia virus TB. Am. J. Pathol. 124:457-468.
114. Zhong, L. T., T. Sarafian, D. J. Kane, A. C. Charles, S. P. Mah, and R. H. Edwards. 1993. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90:4533-4537.